POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE, USP (2 MEQ/ML) 2 mEq
POTASSIUM CHLORIDE : 2 mEq · DIN 02231673 · BAXTER CORPORATION
Health Canada status: CANCELLED POST MARKET
What is POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE, USP (2 MEQ/ML)?
POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE, USP (2 MEQ/ML) 2 mEq contains POTASSIUM CHLORIDE : 2 mEq. It is listed in the Health Canada Drug Product Database under DIN 02231673, held by BAXTER CORPORATION, supplied as SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as cancelled post market, status dated 10-May-2011. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02231673 |
|---|---|
| Brand name | POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE, USP (2 MEQ/ML) |
| Generic / active ingredient | POTASSIUM CHLORIDE : 2 mEq |
| Manufacturer | BAXTER CORPORATION |
| Strength | 2 mEq |
| Dosage form | SOLUTION |
| Route of administration | INTRAVENOUS |
| Schedule | Ethical |
| ATC code | B05XA01 POTASSIUM CHLORIDE |
| AHFS class | 40:12.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 10-May-2011 |
| Original market date | 1997-07-10 00:00:00 |
Is POTASSIUM CHLORIDE in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Active — reported by SANDOZ CANADA INCORPORATED, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
Check availability for POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE, USP (2 MEQ/ML)
What can be used instead?
Other Canadian products sharing ATC code B05XA01 POTASSIUM CHLORIDE. 7 of 17 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE | 20 mEq / 10 ML | SOLUTION | OMEGA LABORATORIES LIMITED | MARKETED | DIN 00402206 |
| POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE | 200 mEq / 100 ML | SOLUTION | OMEGA LABORATORIES LIMITED | MARKETED | DIN 02480034 |
| POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE USP | 149 MG | SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 00037869 |
| POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE USP | 149 MG | SOLUTION | B. BRAUN MEDICAL INC | MARKETED | DIN 02485699 |
| POTASSIUM CHLORIDE INJECTION | 10 mEq / 100 ML | SOLUTION | BAXTER CORPORATION | MARKETED | DIN 02241676 |
| POTASSIUM CHLORIDE INJECTION | 20 mEq / 100 ML | SOLUTION | BAXTER CORPORATION | MARKETED | DIN 02241677 |
| POTASSIUM CHLORIDE INJECTION | 40 mEq / 100 ML | SOLUTION | BAXTER CORPORATION | MARKETED | DIN 02241679 |
| POTASSIUM CHLORIDE INJ 149MG/ML USP | 149 MG | LIQUID | SABEX INC | CANCELLED POST MARKET | DIN 00398047 |
| POTASSIUM CHLORIDE INJ 149MG/ML USP | 149 MG | LIQUID | AYERST LABORATORIES | CANCELLED POST MARKET | DIN 00645842 |
| POTASSIUM CHLORIDE INJ 2MEQ/ML | 2 mEq | LIQUID | INTERNATIONAL MEDICATION SYSTEMS LTD. | CANCELLED POST MARKET | DIN 00243884 |
Who else supplies POTASSIUM CHLORIDE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. POTASSIUM CHLORIDE appears in 158 registered pack listings across 8 markets, published on 6 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.